Neogen Corporation Long-term Line of Credit
Neogen Corporation (NEOG) had Long-term Line of Credit of $0 as of 2022-08-31, per its 10-Q filed 2022-09-30.
Discontinued › Balance Sheet › Liabilities
us-gaap:LineOfCredit · last filed 2022-09-30
- 2022-08-31: Long-term Line of Credit $0.00.
- 2022-05-31: Long-term Line of Credit $0.00.
- 2021-05-31: Long-term Line of Credit $0.00.
- 2020-05-31: Long-term Line of Credit $0.00.
| Period end | Long-term Line of Credit |
|---|---|
| 2022-08-31 | $0.00 10-Q · filed 2022-09-30 |
| 2022-05-31 | $0.00 10-K · filed 2022-07-27 |
| 2021-05-31 | $0.00 10-K · filed 2022-07-27 |
| 2020-05-31 | $0.00 10-K · filed 2021-07-30 |
| 2020-02-29 | $0.00 10-Q · filed 2020-04-03 |
| 2019-11-30 | $0.00 10-Q · filed 2019-12-27 |
| 2019-08-31 | $0.00 10-Q · filed 2019-09-26 |
| 2019-05-31 | $0.00 10-K · filed 2020-07-30 |
| 2018-05-31 | $0.00 10-K · filed 2019-07-30 |
| 2017-05-31 | $0.00 10-K · filed 2018-07-27 |
| 2016-05-31 | $0.00 10-K · filed 2017-07-28 |
| 2016-02-29 | $0.00 10-Q · filed 2016-03-31 |
| 2015-11-30 | $0.00 10-Q · filed 2016-01-08 |
| 2015-08-31 | $0.00 10-Q · filed 2015-09-30 |
| 2015-05-31 | $0.00 10-K · filed 2016-07-29 |
| 2014-11-30 | $0.00 10-Q · filed 2014-12-30 |
| 2014-08-31 | $0.00 10-Q · filed 2014-09-30 |
| 2014-05-31 | $0.00 10-K · filed 2016-07-29 |
| 2013-05-31 | $0.00 10-K · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |